Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Whitefort Capital Management, LP - 20 Feb 2025 SCHEDULE 13D/A Report for Arbutus Biopharma Corp Common Shares, without par value (ABUS)
- Filing manager
- Whitefort Capital Management, LP
- Reporting owner
- Whitefort Capital Master Fund, LP
- Beneficially owned shares
- 13,307,967 shares
- Large-stake signal
-
Ownership
7%Beneficial ownership of this reported class.
Shares
13,307,967 sharesShares beneficially owned as disclosed.
Event date
20 Feb 2025Date tied to the ownership event or amendment.
Accepted by SEC
21 Feb 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 7%
- Symbol
- ABUS
- Shares outstanding
- 190,113,814 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 21 Feb 2025, 09:00:14 UTC
- Event date
- 20 Feb 2025
- Next SEC filing
- 13 Apr 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Whitefort Capital Management, LP disclosed 7% ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS) on 20 Feb 2025.
Key facts
- Whitefort Capital Management, LP filed SCHEDULE 13D/A for Arbutus Biopharma Corp Common Shares, without par value (ABUS).
- Disclosed ownership: 7%.
- Date of event: 20 Feb 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Feb 2025, 09:00.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (6)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Whitefort Capital Master Fund, LP | 7% | 13,307,967 | 0 | 13,307,967 | /s/ David Salanic | David Salanic, Co-Managing Member of Whitefort Capital GP, LLC, its General Partner | 0001704387 |
| Whitefort Capital GP, LLC | 7% | 13,307,967 | 0 | 13,307,967 | /s/ David Salanic | David Salanic, Co-Managing Member | |
| Whitefort Capital Management, LP | 7% | 13,307,967 | 0 | 13,307,967 | /s/ David Salanic | David Salanic, Co-Managing Partner | 0001884931 |
| Whitefort Capital Management GP, LLC | 7% | 13,307,967 | 0 | 13,307,967 | /s/ David Salanic | David Salanic, Co-Managing Member | |
| David Salanic | 7% | 13,307,967 | 0 | 13,307,967 | /s/ David Salanic | David Salanic | |
| Joseph Kaplan | 7% | 13,307,967 | 0 | 13,307,967 | /s/ Joseph Kaplan | Joseph Kaplan |
CIK / CUSIP context first